Zobrazeno 1 - 10
of 66
pro vyhledávání: '"TUGRUL ELVERDI"'
Publikováno v:
Diagnostics, Vol 14, Iss 11, p 1167 (2024)
The aim of this study is to investigate whether there is a cut-off value for PD-L1 expression in large B-cell lymphomas that predicts prognosis, and to clarify the relationship between PD-L1 expression and histopathological as well as clinical parame
Externí odkaz:
https://doaj.org/article/5140809e82344b5489bb5e5c19223c68
Autor:
Eren Gündüz, Hakkı Onur Kırkızlar, Elif Gülsüm Ümit, Sedanur Karaman Gülsaran, Vildan Özkocaman, Fahir Özkalemkaş, Ömer Candar, Tugrul Elverdi, Selin Küçükyurt, Semra Paydaş, Özcan Çeneli, Sema Karakuş, Senem Maral, Ömer Ekinci, Yıldız İpek, Cem Kis, Zeynep Tuğba Güven, Aydan Akdeniz, Tiraje Celkan, Ayşe Hilal Eroğlu Küçükdiler, Gülsüm Akgün Çağlıyan, Ceyda Özçelik Şengöz, Ayşe Karataş, Tuba Bulduk, Alper Özcan, Fatma Burcu Belen Apak, Aylin Canbolat, İbrahim Kartal, Hale Ören, Ersin Töret, Gül Nihal Özdemir, Şule Mine Bakanay Öztürk
Publikováno v:
Turkish Journal of Hematology, Vol 39, Iss 2, Pp 130-135 (2022)
Objective: Castleman disease (CD) is a rare disease also known as angiofollicular lymph node hyperplasia. The two main histological subtypes are the hyaline vascular and plasma cell variants. It is further classified as unicentric CD (UCD) or multice
Externí odkaz:
https://doaj.org/article/90602ce9f9bf437588736f9a063da92f
Autor:
Ali Bazarbachi, Ariane Boumendil, Hervé Finel, Irma Khvedelidze, Joanna Romejko-Jarosinska, Alina Tanase, Saad Akhtar, Tarek Ben Othman, Mohammad Ma’koseh, Boris Afanasyev, Jean Cheikh, Javier Briones, Zafer Gülbas, Rose-Marie Hamladji, Tugrul Elverdi, Didier Blaise, Carmen Martínez, Eleonora Alma, Kazimierz Halaburda, Aida Botelho Sousa, Bertram Glass, Steven Robinson, Silvia Montoto, Anna Sureda
Publikováno v:
LEUKEMIA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Hodgkin lymphoma (HL) patients who relapse after autologous-stem-cell- transplantation (auto-SCT) have traditionally had a poor prognosis. We analyzed 1781 adult HL patients who relapsed between 2006 and 2017 after a first auto-SCT. The 4-year overal
Autor:
Ayse Salihoglu, Yildiz Aydin, Ozden Hatirnaz, Ahmet Emre Eskazan, Ugur Ozbek, Şeniz Öngören, Zafer Baslar, Tugrul Elverdi, Muge Sayitoglu, Teoman Soysal, Muhlis Cem Ar, Isil Erdogan Ozunal
Publikováno v:
Cerrahpasa Medical Journal. 45:221-226
Publikováno v:
Expert Review of Clinical Pharmacology. 14:1183-1188
Acquired or immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a thrombotic microangiopathy with an annual incidence of three cases per 1 million adults [1]. In the pathogenesis, autoimm...
Publikováno v:
Journal of Thrombosis and Haemostasis. 19:2644-2646
Autor:
Zafer Baslar, Muhlis Cem Ar, Teoman Soysal, Ahmet Murt, Ayse Salihoglu, Ahmet Emre Eskazan, Şeniz Öngören, Tugrul Elverdi
Publikováno v:
Annals of Hematology
Hematopoietic stem cell transplantation (HSCT) is a risk factor for viral hepatitis reactivations because it affects lymphocyte number and functions. Latent hepatitis B virus (HBV) may stay in dormant form in hepatocytes and may be reactivated in pro
Autor:
Hasan Sami Goksoy, Sevgi Kalayoglu Besisik, Zübeyde Nur Özkurt, Mehmet Sönmez, Sinem Civriz Bozdag, Irfan Yavasoglu, Tugrul Elverdi, Özgür Mehtap, Orhan Ayyildiz, Ahmet Kursad Gunes, Meliha Nalcaci, Burhan Ferhanoglu, Sebnem Izmir Guner, Meltem Kurt Yuksel, Elif Birtas Atesoglu, Selami Kocak Toprak, Tuğçe Nur Yiğenoğlu, Mustafa Pehlivan, Birol Yildiz, Ozan Salim, Rahsan Yildirim, Tayfur Toptas, Leylagül Kaynar, Ant Uzay, Murat Albayrak, Gülsüm Özet, Güray Saydam, Murat Ozbalak, Fevzi Altuntaş, İpek Yönal Hindilerden, Meltem Ayli, Olga Meltem Akay, Mehmet Hilmi Dogu
Publikováno v:
Web of Science
The AETHERA trial reported an increased progression-free survival (PFS) when brentuximab vedotin (BV) was used as maintenance therapy in high-risk Hodgkin lymphoma (HL) after autologous stem cell transplantation (ASCT). Thus, we aimed to determine th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95a7c1c4c72fda6e1343d54d2a49939b
https://avesis.gazi.edu.tr/publication/details/e5a6129e-18e7-4d48-aaf0-2f5c1ba61d94/oai
https://avesis.gazi.edu.tr/publication/details/e5a6129e-18e7-4d48-aaf0-2f5c1ba61d94/oai
Autor:
Ahmet Emre Eskazan, Tugrul Elverdi
Publikováno v:
Drug Design, Development and Therapy. 13:1251-1258
Thrombotic thrombocytopenic purpura (TTP) is a rare disease with a mortality rate of over 90% if left untreated. Therapeutic plasma exchange (PEX) is the mainstay of treatment of acquired TTP (aTTP), and with the introduction of PEX, the mortality ra
Autor:
Ali Bazarbachi, Ariane Boumendil, Hervé Finel, Irma Khvedelidze, Joanna Romejko-Jarosinska, Alina Tanase, Saad Akhtar, Tarek Ben Othman, Mohammad Ma’koseh, Boris Afanasyev, Jean El-Cheikh, Javier Briones, Zafer Gülbas, Rose-Marie Hamladji, Tugrul Elverdi, Didier Blaise, Carmen Martínez, Eleonora Alma, Kazimierz Halaburda, Aida Botelho Sousa, Bertram Glass, Steven Robinson, Silvia Montoto, Anna Sureda
Publikováno v:
Leukemia. 36:2150-2150